SSX2B

Across TCGA pan-cancer cohorts, SSX2B RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SSX2B’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where SSX2B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SSX2B is over-expressed in tumor.

LIHC and BRCA are the cancer types where SSX2B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SSX2B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.031	.005	2	view →
BRCA	Female	All	+0.003	.047	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SSX2B–LIHC

Open the LIHC breakdown →